ArticleFrontiers in immunology2025
Vericiguat attenuates cyclosporine A-induced nephropathy by targeting the NF-κB/TGF-β1 axis: an integrated network pharmacology, Mendelian randomization, and experimental study.
XuanKe Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.